These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 11200701

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. What has changed with riluzole?
    Meininger V, Lacomblez L, Salachas F.
    J Neurol; 2000 Dec; 247 Suppl 6():VI/19-22. PubMed ID: 19714404
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
    Dib M.
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
    Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O.
    J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
    [Abstract] [Full Text] [Related]

  • 8. An association study of riluzole serum concentration and survival and disease progression in patients with ALS.
    Groeneveld GJ, van Kan HJ, Lie-A-Huen L, Guchelaar HJ, van den Berg LH.
    Clin Pharmacol Ther; 2008 May; 83(5):718-22. PubMed ID: 17898704
    [Abstract] [Full Text] [Related]

  • 9. [The advance in the research and therapeutic trials of amyotrophic lateral sclerosis].
    Moriwaka F, Tashiro K.
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1258-60. PubMed ID: 11464472
    [Abstract] [Full Text] [Related]

  • 10. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
    Roch-Torreilles I, Camu W, Hillaire-Buys D.
    Therapie; 2000 Dec; 55(2):303-12. PubMed ID: 10967703
    [Abstract] [Full Text] [Related]

  • 11. [Riluzole treatment in amyotrophic lateral sclerosis].
    Wokke JH.
    Ned Tijdschr Geneeskd; 1996 Nov 16; 140(46):2265-8. PubMed ID: 8984377
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Riluzole and ALS therapy.
    Hugon J.
    Wien Med Wochenschr; 1996 Nov 16; 146(9-10):185-7. PubMed ID: 8873431
    [Abstract] [Full Text] [Related]

  • 14. Slowing down ALS--is this good or bad?
    Munsat TL.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar 16; 2 Suppl 1():S19-22. PubMed ID: 11465919
    [Abstract] [Full Text] [Related]

  • 15. Toward more efficient clinical trials for amyotrophic lateral sclerosis.
    Cudkowicz ME, Katz J, Moore DH, O'Neill G, Glass JD, Mitsumoto H, Appel S, Ravina B, Kieburtz K, Shoulson I, Kaufmann P, Khan J, Simpson E, Shefner J, Levin B, Cwik V, Schoenfeld D, Aggarwal S, McDermott MP, Miller RG.
    Amyotroph Lateral Scler; 2010 May 03; 11(3):259-65. PubMed ID: 19961263
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Etiological drug therapy for amyotrophic lateral sclerosis].
    Cintas P.
    Rev Neurol (Paris); 2006 Jun 03; 162 Spec No 2():4S220-4S227. PubMed ID: 17128115
    [Abstract] [Full Text] [Related]

  • 18. [Riluzole as a treatment for amyotrophic lateral sclerosis].
    Borrás-Blasco J, Plaza-Macías I, Navarro-Ruiz A, Perís-Martí J, Antón-Cano A.
    Rev Neurol; 1998 Dec 03; 27(160):1021-7. PubMed ID: 9951030
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Tolerance of riluzole in a phase IIIb clinical trial].
    Lacomblez L, Dib M, Doppler V, Faudet A, Robin V, Salachas F, Bensimon G, Meininger V.
    Therapie; 2002 Dec 03; 57(1):65-71. PubMed ID: 12090150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.